Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Chronic kidney disease and positive surgical margins as prognosticators for upper urinary tract urothelial carcinoma patients undergoing radical nephroureterectomy.

Kuroda K, Asakuma J, Horiguchi A, Kawaguchi M, Shinchi M, Masunaga A, Tasaki S, Sato A, Ito K.

Mol Clin Oncol. 2019 May;10(5):547-554. doi: 10.3892/mco.2019.1829. Epub 2019 Mar 20.

2.

Impact of body mass index on clinicopathological outcomes in patients with renal cell carcinoma without anorexia-cachexia syndrome.

Watanabe D, Horiguchi A, Tasaki S, Kuroda K, Sato A, Asakuma J, Ito K, Asano T.

Mol Clin Oncol. 2018 Jan;8(1):47-53. doi: 10.3892/mco.2017.1473. Epub 2017 Oct 27.

3.

[A CASE OF METASTATIC BLADDER UROTHELIAL CARCINOMA WHOSE DISEASE WAS CONTROLLED FOR A RELATIVE LONG PERIOD BY MULTIDISCIPLINARY TREATMENT INCLUDING RADIATION TO A LUNG METASTASIS AND MULTIPLE COURSES OF CHEMOTHERAPY].

Hamada S, Ito K, Kanbara T, Tsujita Y, Yoshii H, Tasaki S, Asakuma J, Horiguchi A, Asano T.

Nihon Hinyokika Gakkai Zasshi. 2017;108(1):35-40. doi: 10.5980/jpnjurol.108.35. Japanese.

4.

Clinical implication of ectopic liver lipid accumulation in renal cell carcinoma patients without visceral obesity.

Watanabe D, Horiguchi A, Tasaki S, Kuroda K, Sato A, Asakuma J, Ito K, Asano T, Shinmoto H.

Sci Rep. 2017 Oct 6;7(1):12795. doi: 10.1038/s41598-017-13209-2.

5.

Clinical outcomes of percutaneous radiofrequency ablation for small renal cancer.

Ito K, Soga S, Seguchi K, Shinchi Y, Masunaga A, Tasaki S, Kuroda K, Sato A, Asakuma J, Horiguchi A, Shinmoto H, Kaji T, Asano T.

Oncol Lett. 2017 Jul;14(1):918-924. doi: 10.3892/ol.2017.6262. Epub 2017 May 26.

6.

[CLINICAL ANALYSIS ABOUT PERCUTANEOUS NEEDLE BIOPSY FOR RENAL MASSES].

Asakuma J, Isono M, Tsujita Y, Tasaki S, Kuroda K, Sato A, Horiguchi A, Seguchi K, Ito K, Asano T.

Nihon Hinyokika Gakkai Zasshi. 2017;108(2):57-63. doi: 10.5980/jpnjurol.108.57. Japanese.

7.

Increased nucleophosmin expression is a strong predictor of recurrence and prognosis in patients with N0M0 upper tract urothelial carcinoma undergoing radical nephroureterectomy.

Sawazaki H, Ito K, Asano T, Kuroda K, Sato A, Asakuma J, Horiguchi A, Seguchi K, Asano T.

World J Urol. 2017 Jul;35(7):1081-1088. doi: 10.1007/s00345-016-1977-1. Epub 2016 Nov 24.

PMID:
27885451
8.

Preoperative serum docosahexaenoic acid level predicts prognosis of renal cell carcinoma.

Tasaki S, Horiguchi A, Asano T, Kuroda K, Sato A, Asakuma J, Ito K, Asano T, Asakura H.

Mol Clin Oncol. 2016 Jul;5(1):69-73. Epub 2016 May 9.

9.

Preoperative risk factors for extraurothelial recurrence in N0M0 patients with renal pelvic cancer treated by radical nephroureterectomy.

Ito K, Asakuma J, Kuroda K, Tachi K, Sato A, Horiguchi A, Seguchi K, Asano T.

Mol Clin Oncol. 2016 Apr;4(4):530-536. Epub 2016 Jan 28.

10.

Surgical removal of the solitary metastasis of renal cell carcinoma in the third ventricle using an interhemispheric transcallosal trans-choroidal approach.

Otani N, Wada K, Kumagai K, Takeuchi S, Nagatani K, Tomura S, Osada H, Asakuma J, Mori K.

Asian J Neurosurg. 2015 Jan-Mar;10(1):58. doi: 10.4103/1793-5482.151526.

11.

Clinical characteristics and prognosis of patients with renal cell carcinoma and liver metastasis.

Hamada S, Ito K, Kuroda K, Sato A, Asakuma J, Horiguchi A, Seguchi K, Asano T.

Mol Clin Oncol. 2015 Jan;3(1):63-68. Epub 2014 Sep 29.

12.

Tumor necrosis is a strong predictor for recurrence in patients with pathological T1a renal cell carcinoma.

Ito K, Seguchi K, Shimazaki H, Takahashi E, Tasaki S, Kuroda K, Sato A, Asakuma J, Horiguchi A, Asano T.

Oncol Lett. 2015 Jan;9(1):125-130. Epub 2014 Nov 4.

13.

Clinical significance of p21-activated kinase 1 expression level in patients with upper urinary tract urothelial carcinoma.

Kuroda K, Asakuma J, Asano T, Horiguchi A, Isono M, Tsujita Y, Sato A, Seguchi K, Ito K, Asano T.

Jpn J Clin Oncol. 2015 Jan;45(1):103-10. doi: 10.1093/jjco/hyu163. Epub 2014 Oct 16.

PMID:
25324479
14.

Modified posterior musculofascial plate reconstruction decreases the posterior vesicourethral angle and improves urinary continence recovery in patients undergoing laparoscopic radical prostatectomy.

Ito K, Kenji S, Yoshii H, Hamada S, Asakuma J, Tasaki S, Kuroda K, Sato A, Horiguchi A, Asano T.

Mol Clin Oncol. 2013 Nov;1(6):970-976. Epub 2013 Sep 12.

15.

Prognostic impact of fatty acid synthase expression in upper urinary tract urothelial carcinoma.

Hamada S, Horiguchi A, Asano T, Kuroda K, Asakuma J, Ito K, Asano T, Miyai K, Iwaya K.

Jpn J Clin Oncol. 2014 May;44(5):486-92. doi: 10.1093/jjco/hyu020. Epub 2014 Mar 18.

PMID:
24643292
16.

Preoperative risk factors for extraurothelial recurrence in patients with ureteral cancer treated with radical nephroureterectomy.

Ito K, Kuroda K, Asakuma J, Hamada S, Tachi K, Tasaki S, Sato A, Horiguchi A, Seguchi K, Asano T.

J Urol. 2014 Jun;191(6):1685-92. doi: 10.1016/j.juro.2013.12.048. Epub 2014 Jan 11.

PMID:
24423440
17.

[The diagnostic value of pre-biopsy magnetic resonance imaging for precise detection of clinically localized prostate cancer compared to post-biopsy setting].

Takahashi M, Horiguchi A, Tasaki S, Kuroda K, Sato A, Asakuma J, Seguchi K, Hayakawa M, Ito K, Asano T, Tamura C, Shinmoto H.

Hinyokika Kiyo. 2013 Dec;59(12):769-73. Japanese.

18.

[The efficacy of direct vision internal urethrotomy for male urethral stricture].

Isono M, Horiguchi A, Tasaki S, Kuroda K, Sato A, Asakuma J, Seguchi K, Ito K, Hayakawa M, Asano T.

Nihon Hinyokika Gakkai Zasshi. 2012 Nov;103(6):691-6. Japanese.

PMID:
24261192
19.

[Causes and salvage of failed urethroplasties for traumatic urethral injury].

Horiguchi A, Azuma R, Tasaki S, Hamada S, Kuroda K, Sato A, Asakuma J, Seguchi K, Hayakawa M, Ito K, Asano T.

Nihon Hinyokika Gakkai Zasshi. 2013 Jul;104(4):589-97. Japanese.

PMID:
23971367
20.

[Evaluation of clinical results in patients undergoing laparoscopic nephroureterectomy].

Hamada S, Ito K, Takahashi M, Isono M, Tasaki S, Yoshii H, Kuroda K, Satou A, Asakuma J, Seguchi K, Horiguchi A, Sumitomo M, Asano T.

Hinyokika Kiyo. 2013 Apr;59(4):217-23. Japanese.

21.

Prognostic factors for upper urinary tract urothelial carcinoma after nephroureterectomy.

Kuroda K, Asakuma J, Horiguchi A, Tasaki S, Yoshii H, Sato A, Ito K, Seguchi K, Sumitomo M, Asano T.

Urol Int. 2012;88(2):225-31. doi: 10.1159/000335274. Epub 2012 Jan 11.

PMID:
22236640
22.

Prediction of biochemical recurrence after radical prostatectomy using peritumoral lymphatic vessel density in biopsy specimens in patients with localized prostate cancer.

Kuroda K, Horiguchi A, Asano T, Tasaki S, Yoshii H, Sato A, Asakuma J, Ito K, Seguchi K, Sumitomo M, Asano T.

Urol Int. 2012;88(1):18-24. doi: 10.1159/000335275. Epub 2012 Jan 4.

PMID:
22222198
23.

Glucose-regulated protein 78 positivity as a predictor of poor survival in patients with renal cell carcinoma.

Kuroda K, Horiguchi A, Asano T, Ito K, Asakuma J, Sato A, Yoshii H, Hayakawa M, Sumitomo M, Asano T.

Urol Int. 2011;87(4):450-6. doi: 10.1159/000330883. Epub 2011 Nov 10.

PMID:
22076227
24.

[Clinical experience of 52 patients undergoing laparoscopic radical prostatectomy].

Ito K, Yoshii H, Miyajima A, Kanbara T, Tsujita Y, Kuroda K, Sato A, Asakuma J, Horiguchi A, Seguchi T, Sumitomo M, Hayakawa M, Asano T.

Hinyokika Kiyo. 2011 May;57(5):227-36. Japanese.

25.

Impact of postoperative C-reactive protein level on recurrence and prognosis in patients with N0M0 clear cell renal cell carcinoma.

Ito K, Yoshii H, Sato A, Kuroda K, Asakuma J, Horiguchi A, Sumitomo M, Asano T.

J Urol. 2011 Aug;186(2):430-5. doi: 10.1016/j.juro.2011.03.113. Epub 2011 Jun 15.

PMID:
21679988
26.

Transurethral resection of the prostate immediately after high-intensity focused ultrasound treatment for prostate cancer.

Sumitomo M, Asakuma J, Sato A, Ito K, Nagakura K, Asano T.

Int J Urol. 2010 Nov;17(11):924-30. doi: 10.1111/j.1442-2042.2010.02638.x. Epub 2010 Oct 4.

27.

[A case of labial adhesion in a reproductive woman].

Tsujita Y, Asakuma J, Kanbara T, Yoshii T, Azuma R, Sumitomo M, Asano T.

Hinyokika Kiyo. 2010 Aug;56(8):463-5. Japanese.

28.

Anterior perirectal fat tissue thickness is a strong predictor of recurrence after high-intensity focused ultrasound for prostate cancer.

Sumitomo M, Asakuma J, Yoshii H, Sato A, Horiguchi A, Ito K, Nagakura K, Asano T.

Int J Urol. 2010 Sep;17(9):776-82. doi: 10.1111/j.1442-2042.2010.02585.x. Epub 2010 Jun 21.

29.

STAT3 inhibitor WP1066 as a novel therapeutic agent for renal cell carcinoma.

Horiguchi A, Asano T, Kuroda K, Sato A, Asakuma J, Ito K, Hayakawa M, Sumitomo M, Asano T.

Br J Cancer. 2010 May 25;102(11):1592-9. doi: 10.1038/sj.bjc.6605691. Epub 2010 May 11.

30.

[Oral mucosa graft urethroplasty for complicated urethral strictures].

Horiguchi A, Sumitomo M, Kanbara T, Tsujita Y, Yoshii T, Yoshii H, Satoh A, Asakuma J, Ito K, Hayakawa M, Asano T.

Nihon Hinyokika Gakkai Zasshi. 2010 Mar;101(3):547-53. Japanese.

PMID:
20387514
31.

[Urothelial carcinoma clear cell variant of the urinary bladder : a case report].

Isono M, Asano T, Shirotake S, Tasaki S, Asakuma J, Satoh M, Kimura F, Dai Y, Aida S.

Hinyokika Kiyo. 2010 Mar;56(3):163-5. Review. Japanese.

32.

Clinical impact of the presence of the worst nucleolar grade in renal cell carcinoma specimens.

Ito K, Yoshii H, Asakuma J, Sato A, Horiguchi A, Sumitomo M, Hayakawa M, Asano T.

Jpn J Clin Oncol. 2009 Sep;39(9):588-94. doi: 10.1093/jjco/hyp068. Epub 2009 Jun 25.

PMID:
19556339
33.

[Adrenal metastasis of lung adenocarcinoma with unusual sites of lymph node metastasis and concomitant renal cell carcinoma: a case report].

Otsuki H, Ito K, Kosaka T, Mikami H, Yoshii H, Asakuma J, Kaji T, Asano T, Hayakawa M.

Hinyokika Kiyo. 2007 Dec;53(12):879-82. Japanese.

34.

Leptin promotes invasiveness of murine renal cancer cells via extracellular signal-regulated kinases and rho dependent pathway.

Horiguchi A, Sumitomo M, Asakuma J, Asano T, Zheng R, Asano T, Nanus DM, Hayakawa M.

J Urol. 2006 Oct;176(4 Pt 1):1636-41.

PMID:
16952706
35.

Increased serum leptin levels and over expression of leptin receptors are associated with the invasion and progression of renal cell carcinoma.

Horiguchi A, Sumitomo M, Asakuma J, Asano T, Zheng R, Asano T, Nanus DM, Hayakawa M.

J Urol. 2006 Oct;176(4 Pt 1):1631-5.

PMID:
16952705
36.

[A case of primary leiomyosarcoma of the ureter].

Shirotake S, Sumitomo M, Asakuma J, Asano T, Aiko S, Hayakawa M.

Hinyokika Kiyo. 2006 Jan;52(1):41-5. Japanese.

37.

[Clinical experience of laparoscopic adrenalectomy: the National Defense Medical College experience].

Ito K, Asano T, Sumitomo M, Mizuguchi Y, Yamanaka M, Asakuma J, Takahashi E, Yoshii H, Horiguchi A, Kimura F, Miyajima A, Hayakawa M.

Hinyokika Kiyo. 2005 Dec;51(12):783-8. Japanese.

38.

3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor, fluvastatin, as a novel agent for prophylaxis of renal cancer metastasis.

Horiguchi A, Sumitomo M, Asakuma J, Asano T, Asano T, Hayakawa M.

Clin Cancer Res. 2004 Dec 15;10(24):8648-55.

39.

Impact of caveolin-1 expression on clinicopathological parameters in renal cell carcinoma.

Horiguchi A, Asano T, Asakuma J, Asano T, Sumitomo M, Hayakawa M.

J Urol. 2004 Aug;172(2):718-22.

PMID:
15247769
40.
41.

Chemosensitization of androgen-independent prostate cancer with neutral endopeptidase.

Sumitomo M, Asano T, Asakuma J, Asano T, Nanus DM, Hayakawa M.

Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):260-6.

42.
43.
44.

Protein kinase Cdelta amplifies ceramide formation via mitochondrial signaling in prostate cancer cells.

Sumitomo M, Ohba M, Asakuma J, Asano T, Kuroki T, Asano T, Hayakawa M.

J Clin Invest. 2002 Mar;109(6):827-36.

45.

Incidentally discovered giant renal arteriovenous malformation.

Asakuma J, Miyajima A, Sawazaki H, Mizuguchi Y, Seguchi K, Ito K, Asano T, Ogata S, Tamai S, Hayakawa M.

Int J Urol. 2001 Jun;8(6):322-5.

46.

Paradoxical worsening of tuberculosis after anti-TB therapy in a kidney transplant recipient.

Asano T, Kawamoto H, Asakuma J, Tanimoto T, Kobayashi H, Hayakawa M.

Transplant Proc. 2000 Nov;32(7):1960-2. No abstract available.

PMID:
11120020

Supplemental Content

Loading ...
Support Center